Content Hub
Content Hub
Amphista Therapeutics – Personal Highlights from the 3rd Annual TPD Summit
An Interview with Gwenn M. Hansen, Ph.D
Chief Scientific Officer
Nurix Therapeutics
TPD 2020 Post Event Report
An Interview with Ian Churcher,
Chief Scientific Officer, Amphista Therapeutics
